Fetal and maternal toxoplasmosis

Recent Advances in Toxoplasmosis Research

Volumn , Issue , 2014, Pages 1-33

  Oz, Helieh S ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Atovaquone; Congenital Toxoplasmosis; Diclazuril; Fetal Maternal; Toxoplasma

Indexed keywords

EID: 84905178589     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (130)

1. Hoffmann S, Batz MB, Morris JG Jr. Annual cost of illness and quality-adjusted life year losses in the United States due to 14 foodborne pathogens. J. Food Prot. 2012 Jul;75(7):1292-302. doi: 10.4315/0362-028X.JFP-11-417.
2. Hotez PJ. Neglected Infections of Poverty in the United States of America. PLOs ONE 2008,2:256:1-11.
3. Jones JL, Kruszon-Moran D, Wilson M, Mcquillan G, Navin T, Mcauley JB. Toxoplasma gondii infection in the United States: Seroprevalence and risk factors. Amer. J.Epidemiol. 2001;154:357-365.
4. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, Griffin PM, Tauxe R V. Food-related illness and death in the United States. Emerg. Infect. Dis. 1999,5: 606-625.
5. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A, Roy SL, Jones JL, Griffin PM. Foodborne Illness Acquired in the United States Major Pathogens. Emerg. Infect. Dis. www.cdc.gov/eid · Vol. 17, No. 1, January 2011
6. Prandota J. The importance of Toxoplasma gondii infection in diseases presenting with headaches. Headaches and aseptic meningitis may be manifestations of the Jarisch-Herxheimer reaction. Int. J.Neurosci. 2009;119(12):2144-82. Review.
7. Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli AE, Denkers EY. Dendritic Cells Expressing Plasmacytoid Marker PDCA-1 Are Trojan Horses during Toxoplasma gondii Infection. J.Immunol. 2008,18: 8485-8491.
8. Elsheikha HM, Khan NA. Protozoa traversal of the blood brain barrier to invade the central nervous system. FEMS Microbiol. Rev. 2010,34 532-553.
9. Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int. J.Parasitol. 2008;38:1257-78.
10. Boyer K, Hill D, Mui E, Wroblewski K, Karrison T, Dubey JP, Sautter M, Noble AG, Withers S, Swisher C, Heydemann P, Hosten T, Babiarz J, Lee D, Meier P, McLeod R. Toxoplasmosis Study Group. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America. Clin. Infect. Dis. 2011 Dec;53(11):1081-9. doi: 10.1093/cid/cir667.
11. Dubey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology 2012 Sep;139(11):1375-424. doi: 10.1017/S0031182012000765.
12. Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R. Mother-to child transmission of toxoplasmosis: Risk estimates for clinical counseling. Lancet 1999,353,1829-1833
13. Remington JS, McLeod R, Thulliez P, Desmonts G. Toxoplasmosis. In "Infectious Diseases of the Fetus and Newborn Infant" (Remington JS, Klein JO, Wilson CB, Baker CJ, eds), 6th edn, 2006, pp. 947-1091. Philadelphia: Elsevier Saunders.
14. Gilbert R, Gras L. Effect of timing and type of treatment on the risk of mother to child transmission of Toxoplasma gondii. Bjog2003:110: 112-120.
15. Gras L, Wallon M, Pollak A, Cortina-Borja M, Evengard B, et al. Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta.Paediatr.2005:94: 1721-1731.
16. McLeod R, Boyer K, Karrison T, Kasza K, Swisher C, et al. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study. Clin. Infect. Dis.2006: 42: 1383-1394.
17. Mack DG, Johnson JJ, Roberts F, Roberts CW, Estes RG, et al. HLA class II genes modify outcome of Toxoplasma gondii infection. Int. J.Parasitol. 1999:29:1351-1358.
18. Jamieson SE, de Roubaix L-A, Cortina-Borja M, Tan HK, Mui EJ, et al. Genetic and epigenetic factors at COL2A1 and ABCA4 Influence clinical outcome in congenital toxoplasmosis. PLoS ONE 2008,3: e2285. doi:10.1371/journal.pone.0002285.
19. Muzzio DO, Soldati R, Rolle L, Zygmunt M, Zenclussen AC, Jensen F. B-1a B Cells Regulate T Cell Differentiation Associated with Pregnancy Disturbances. Front Immunol. 2014;5: 6. 2014 January 21. doi: 10.3389/fimmu.2014.00006.
20. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N. Engl. J. Med.2001,345, 1400-1408.
21. Amodio G1, Mugione A, Sanchez AM, Vigano P, Candiani M, Somigliana E, Roncarolo MG, Panina-Bordignon P, Gregori S. HLA-G expressing DC-10 and CD4(+) T cells accumulate in human decidua during pregnancy. Hum.Immunol. 2013 Apr ;74(4):406-11. doi: 10.1016/j.humimm.2012.11.031.
22. Chen M1, Aosai F, Mun HS, Norose K, Hata H, Yano A. Anti-HSP70 autoantibody formation by B-1 cells in Toxoplasma gondii-infected mice. Infect.Immun. 2000 Sep;68(9):4893-9.
23. Romero R, Espinoza J, Mazor M. Can endometrial infection/inflammation explain implantation failure, spontaneous abortion, and preterm birth after in vitro fertilization? Fertil.Steril 2004,82, 799-804.
24. Senegas A, Villard O, Neuville A, Marcellin L, Pfaff AW, Steinmetz T, Mousli M, Klein JP, Candolfi E, Toxoplasma gondii-induced foetal resorption in mice involves interferon-cinduced apoptosis and spiral artery dilation at the maternofoetal interface. Int J Parasitol 2009,39: 481-487.
25. Sibley LD, Mordue DG, Su C, Robben PM, Howe DK. Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii. Philos Trans. R. Soc.LondB. Biol. Sci. 2002,29;357:81-8.
26. Oz HS, Chen T, de Villiers WJS. Green Tea Polyphenols and Sulfasalazine have Parallel Anti-inflammatory Properties in Colitis Models, Front Immunol 2013,4, 132:1-10.
27. Oz HS, Ray M, Chen T, McClain C. Efficacy of a TGF-ß2 Containing Nutritional Support Formula in a Murine Model of IBD. J. Amer Coll Nutri 2004,23: 220-226.
28. Gazzinelli RT, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kühn R, Müller W, Trinchieri G, Sher A. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J.Immunol. 1996 Jul 15;157(2):798-805.
29. Rozenfeld C, Martinez R, Figueiredo RT, Bozza MT, et al. Soluble factors released by Toxoplasma gondii-infected astrocytes down-modulate nitric oxide production by gamma interferon-activated microglia and prevent neuronal degeneration. Infect. Immun. 2003;71:2047-57.
30. Buxton D, Thomson K, Maley S, Wright S, Bos HJ. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet. Rec. 1991;129:89-93.
31. Wolf A, Cowen D, Paige B. Human toxoplasmosis: occurrence in infants as an encephalomyelitis verification by transmission to animals. Science 1939,89, 226-227.
32. Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R. Congenital toxoplasmosis: A review. Obst. Gynecol.Surv. 2001,56: 296-305.
33. Oz HS, Tobin T. Atovaquone Ameliorates Gastrointestinal Toxoplasmosis Complications in a Pregnancy model. Med. Sci. Mon. 18,2012, pp. BR337-345.
34. Wong SY, Remington JS. Toxoplasmosis in pregnancy. Clin. Infect. Dis. 1994,18:853-861.
35. Carral L, Kaufer F, Olejnik P, Freuler C, Durlach R. [Prevention of congenital toxoplasmosis in a Buenos Aires hospital]. Medicina (B Aires). 2013;73(3):238-42.
36. Brown AS, Schaefer CA, Quesenberry CP Jr, Liu L, Babulas VP, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring.Am. J. Psychiatry 2005;162:767-73.
37. Bachmann S, Schröder J, Bottmer C, Torrey EF, Yolken RH. Psychopathology in first-episode schizophrenia and antibodies to Toxoplasmagondii. Psychopathology 2005;38:87-90.
38. Wang HL, Wang GH, Li QY, Shu C, Jiang MS, Guo Y. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia ActaPsychiatr. Scand.2006;114:40-8.
39. Flegr J. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis.J. Exp. Biol.2013 Jan 1;216(Pt 1):127-33. doi: 10.1242/jeb.073635.
40. Fekadu A, Shibre T, Cleare AJ. Toxoplasmosis as a cause for behaviour disorders--overview of evidence and mechanisms. Folia. Parasitol 2010 Jun;57(2):105-113.
41. Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr. Bull 2007 May;33(3):729-736.
42. Pedersen MG, Mortensen PB, Norgaard-Pedersen B, Postolache TT. Toxoplasma gondii infection and self-directed violence in mothers. Arch Gen Psych 2012 Nov;69(11): 1123-1130.
43. Zhang Y, Traskman-Bendz L, Janelidze S, et al. Toxoplasma gondii immunoglobulin G antibodies and nonfatal suicidal self-directed violence. J clin psychiatry 2012 Aug;73(8):1069-1076.
44. Kaňková S, Sulc J, Křivohlavá R, Kuběna A, Flegr J. Slower postnatal motor development in infants of mothers with latent toxoplasmosis during the first 18 months of life. Early Hum. Dev. 2012 Nov;88(11):879-84. doi: 10.1016/j.earlhumdev.2012.07.001.
45. Mizgajska-Wiktor H, Jarosz W, Andrzejewska I, Krzykala M, Janowski J, Kozlowska M. Differences in some developmental features between Toxoplasma gondii-seropositive and seronegative school children. Folia Parasitol (Praha). 2013 Nov;60(5):416-24.
46. Devleesschauwer B, Ale A, Torgerson P, Praet N, Maertens de Noordhout C, Pandey BD, Pun SB, Lake R, Vercruysse J, Joshi DD, Havelaar AH, Duchateau L, Dorny P, Speybroeck N. The burden of parasitic zoonoses in Nepal: a systematic review. PLoSNegl. Trop. Dis. 2014 Jan 2;8(1):e2634. doi: 10.1371/journal.pntd.0002634. eCollection 2014.
47. Trainor PA. Craniofacial birth defects: The role of neural crest cells in the etiology andpathogenesis of Treacher Collins syndrome and the potential for prevention. Stowers Institute for Medical Research, Kansas City, Missouri. Am. J. Med. Genet. A. 2010 Dec;152A(12):2984-94. doi: 10.1002/ajmg.a.33454. Review.
48. Drangsholt MT, LeResche L, Ramsey DS, Herring S, Dworkin SF. Comments on pediatric internal derangements. Am. J.Orthod.Dentofacial. Orthop. 1994 Mar;105(3):38A-39A.
49. Dunn KM, Jordan KP, Mancl L, Drangsholt MT, Le Resche L. Trajectories of pain inadolescents: a prospective cohort study. Pain 2011 Jan;152(1):66-73.
50. Macfarlane TV, Kenealy P, Kingdon HA, Mohlin B, Pilley JR, Mwangi CW, Hunter L, Richmond S, Shaw WC. Orofacial pain in young adults and associated childhood andadulthood factors: results of the population study, Wales, United Kingdom. Community Dent Oral Epidemiol. 2009 Oct;37(5):438-50.
51. Holková R, Molnárová A, Nemec R, Brozman M, Fábry J, Horáková E. [Relation between toxoplasmosis and orofacial clefts in children]. Bratisl Lek Listy. 1994,95:64-7.
52. Gu SZ, Lu S, Ma YW. [Study on the relationship between congenital toxoplasmosis andmonsters of cleft lip and palate accompanied by multiple malformation]. Shanghai KouQiang Yi Xue. 1992;1:66-9.
53. Gabka J. [Etiology of cleft palate, with special reference to toxoplasmosis.] Dtsch Zahnarztl Z. 1954 Sep 15;9:1043-7.
54. Gabka J. [Etiology of labial, oral and palatal fissures with special reference toToxoplasmosis.] Dtsch Stomatol. 1953 ;3:294-300.
55. Glass RB, Fernbach SK, Norton KI, Choi PS, Naidich TP. The Infant Skull: A Vault of Information. Radiographics 2004;24:507-522.
56. Amendoeira MR, Coutinho SG. Isolation of Toxoplasma gondii from the saliva and tonsils ofa three-year-old child. J. Infect. Dis. 1982;145:587.
57. Köybaşi S, Süslü AE, Yigit B, Boran C. Acquired toxoplasmosis of the buccal area with extranodular involvement: report of an unusual case. Ear Nose Throat J. 2009;88:E12-4.
58. Calore EE, Minkovski R, Khoury Z, Seguro AC, Perez Calore NM, Cavaliere MJ. Skeletalmuscle pathology in 2 siblings infected with Toxoplasma gondii. J.Rheumatol. 2000;27:1556-9.
59. Pergola G, Cascone A, Russo M. Acute pericarditis and myocarditis by Toxoplasma gondii in an immunocompetent young man: a case report. Infez Med. 2010;18:48-52.
60. Sumi M, Aosai F, Norose K, Takeda W, Kirihara T, Sato K, Fujikawa Y, Shimizu I, Ueki T, Hirosima Y, Ueno M, Ichikawa N, Watanabe M, Kobayashi H. Acute exacerbation of Toxoplasma gondii infection after hematopoietic stem cell transplantation: five case reports among 279 recipients. Int. J.Hematol. 2013 Aug;98(2):214-22. doi: 10.1007/s12185-013-1379-8. Epub 2013 Jun 8.
61. Munir A, Zaman M, Eltorky M. Toxoplasma gondii pneumonia in a pancreas transplant patient. South Med. J. 2000 Jun;93(6):614-7.
62. Dudley NJ, Balfour AH. Non-Hodgkin's lymphoma presenting as 'chronic activetoxoplasmosis' Postgrad Med. J, 1988 Nov;64(757):883-885.
63. Parenti DM, Steinberg W, Kang P. Infectious causes of acute pancreatitis. Pancreas 1996 Nov;13(4):356-71.
64. Smart ME, Downey RS, Stockdale PH. Toxoplasmosis in a cat associated with cholangitis and progressive pancreatitis. Can. Vet. J. 1973 Dec;14(12):313-6.
65. Petrak M, carpenter J. Feline toxoplasmosis. J. Am. Vet. Med. Ass. 1965;146: 728-734.
66. Segall L, Moal MC, Doucet L, Kergoat N, Bourbigot B. Toxoplasmosis-associated hemophagocytic syndrome in renal transplantation. Transpl Int. 2006 Jan;19(1):78-80.
67. Hou S. Pregnancy in chronic renal insufficiency and end-stage renal disease. Am. J. Kidney Dis. 1999 Feb;33(2):235-52.
68. Hou S. Pregnancy in renal transplant recipients. Adv. Ren. Replace Ther. 2003 Jan;10(1):40-7.
69. Ordemann R, Petzold K, Hölig K, Schaffer B, Mauersberger S, Ehninger G. Experiences of the Dresdner Cord Blood Bank, supported by the Deutsche Knochenmarkspenderdatei. Semin.Thromb.Hemost. 1999;25(6):575-8.
70. Hohlfeld P, Forestier F, Kaplan C, Tissot JD, Daffos F. Fetal thrombocytopenia: a retrospective survey of 5,194 fetal blood samplings. Blood. 1994 Sep 15;84(6):1851-6.
71. Michez D, Quintart C, Noël E, Lepage P. [Peripheral thrombopenicpurpura associated with acquired toxoplasmosis]. Rev. Med.Brux. 1998 Jun;19(3):135-7.
72. Armstrong L, Isaacs D, Evans N. Severe neonatal toxoplasmosis after third trimester maternal infection. Pediatr Infect. Dis. J. 2004 Oct;23(10):968-9. Pediatr Infect. Dis. J. 2004 Oct;23(10):968-9.
73. Shapira Y, Agmon-Levin N, Selmi C, Petríková J, Barzilai O, Ram M, Bizzaro N, Valentini G, Matucci-Cerinic M, Anaya JM, Katz BS, Shoenfeld Y. Prevalence of anti-Toxoplasma antibodies in patients with autoimmune diseases. J.Autoimmun. 2012 Aug;39(1-2):112-6. doi: 10.1016/j.jaut.2012.01.001.
74. Oz HS, Chen T, Ebersole JL, A Model for Chronic Mucosal Inflammation in IBD and Periodontitis Dig. Dis. Sci. DOI 10.1007/s10620-009-1031-x
75. Brandtzaeg P. Inflammatory bowel disease: Clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses? Acta Odontol. Scand. 2001;59: 235-243.
76. Epple HJ. Therapy- and non-therapy-dependent infectious complications in inflammatory bowel disease. Dig. Dis. 2009;27(4):555-9. doi: 10.1159/000233297.
77. Cavalcanti MG, Mesquita JS, Madi K, Feijó DF, Assunçào-Miranda I, Souza HS, Bozza MT. MIF participates in Toxoplasma gondii-induced pathology following oral infection. PLoS One. 2011;6(9):e25259. doi: 10.1371/journal.pone.0025259.
78. Oz HS, Tobin T. Diclazuril protects against maternal gastrointestinal syndrome and congenital toxoplasmosis. Int. J.Clin. Med., Special issue: Treatment of liver diseases, 2014,5, 93-101, Online January 2014 (http://www.scirp.org/journal/ijcm)
79. Oz HS. Novel Synergistic Protective Efficacy of Atovaquone and Diclazuril on Fetal Maternal Toxoplasmosis. International J Clinical Medicine, 2014 5(15), 921-932, Sci Res. http://dx.doi.org/10.4236/ijcm.2014.515124 , PMID: 25210646
80. Erridge C, Duncan SH, Bereswill S, Heimesaat MM. The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2,4, and 5. PLoS One. 2010 Feb 9;5(2):e9125. doi: 10.1371/journal.pone.0009125.
81. Oz HS, Ebersole J, de Villiers W. The Macrophage Pattern Recognition Scavenger Receptors SR-A and CD36 protect against microbial induced pregnancy loss. Inflam Res. 2011:60:93-97.
82. Lidar M, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Bizzaro N, Tonutti E, Maieron R, Chowers Y, Bar-Meir S, Shoenfeld Y. Infectious serologies and autoantibodies in inflammatory bowel disease: insinuations at a true pathogenic role. Ann. N Y Acad. Sci. 2009 Sep;1173:640-8. doi: 10.1111/j.1749-6632.2009.04673.x.
83. Carter CJ. Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders. CarterJ.Pathog. 2013;2013:965046. doi: 10.1155/2013/965046.
84. Thjodleifsson B, Olafsson I, Gislason D, Gislason T, Jögi R, Janson C. Infections and obesity: A multinational epidemiological study. Scand. J. Infect. Dis. 2008;40(5):381-6.
85. Kaňková S, Sulc J, Flegr J. Increased pregnancy weight gain in women with latent toxoplasmosis and RhD-positivity protection against this effect. Parasitology. 2010 Oct;137(12):1773-9. doi: 10.1017/S0031182010000661.
86. Hermes-Uliana C, Pereira-Severi LS, Luerdes RB, Franco CL, da Silva AV, Araújo EJ, Sant'AnaDde M. Chronic infection with Toxoplasma gondii causes myenteric neuroplasticity of the jejunum in rats. Auton Neurosci. 2011 Feb 24;160(1-2):3-8. doi: 10.1016/j.autneu.2010.09.003.
87. Picard F, Arsenijevic D, Richard D, DeshaiesY. Responses of adipose and muscle lipoprotein lipase to chronic infection and subsequent acute lipopolysaccharide challenge. Clin.Diagn Lab.Immunol. 2002 Jul;9(4):771-6.
88. Portugal LR, Fernandes LR, Alvarez-Leite JI. Host cholesterol and inflammation as common key regulators of toxoplasmosis and artherosclerosis development. Expert Rev. Anti. Infect.Ther. 2009;7(7):807-19. doi: 10.1586/eri.09.60.
89. Lige B, Sampels V, Coppens I. Characterization of a second sterol-esterifying enzyme in Toxoplasma highlights the importance of cholesterol storage pathways for the parasite. Mol.Microbiol. 2013;87(5):951-67. doi: 10.1111/mmi.12142.
90. House PK, Vyas A, Sapolsky R. Predator cat odors activate sexual arousal pathways in brains of Toxoplasma gondii infected rats. PLoS One. 2011;6(8):e23277. doi: 10.1371/journal.pone.0023277.
91. Knight K. How pernicious parasites turn victims into zombies. J. Exp. Biol. 2013 Jan 1;216(Pt 1):i-iv.
92. Wanderley FS, Porto WJ, Câmara DR, da Cruz NL, Feitosa BC, Freire RL, de Moraes EP, Mota RA. Experimental vaginal infection of goats with semen contaminated with the "CPG" strain of Toxoplasma gondii. J.Parasitol. 2013 Aug;99(4):610-3. doi: 10.1645/12-126.1.
93. Arantes TP, Lopes WD, Ferreira RM, Pieroni JS, Pinto VM, Sakamoto CA, Costa AJ. Toxoplasma gondii: Evidence for the transmission by semen in dogs. Exp.Parasitol. 2009 Oct;123(2):190-4. doi: 10.1016/j.exppara.2009.07.003.
94. Lopes WD, Rodriguez JD, Souza FA, dos Santos TR, dos Santos RS, Rosanese WM, Lopes WR, Sakamoto CA, da Costa AJ. Sexual transmission of Toxoplasma gondii in sheep. Vet.Parasitol. 2013 Jul 1;195(1-2):47-56. doi: 10.1016/j.vetpar.2012.12.056.
95. Petersen E, Schmidt DR. Sulfadiazine and pyrimethamine in the postnatal treatment of congenital toxoplasmosis: what are the options? Expert Rev.Anti InfectTher. 2003;1:175-82.
96. Teixeira LE, Kanunfre KA, Shimokawa PT, Targa LS, Rodrigues JC, Domingues W, Yamamoto L, Okay TS. The performance of four molecular methods for the laboratory diagnosis of congenital toxoplasmosis in amniotic fluid samples. Rev. Soc. Bras Med. Trop. 2013 Sep-Oct;46(5):584-8.
97. Fricker-Hidalgo H, Cimon B, Chemla C, Darde ML, Delhaes L, L'ollivier C, Godineau N, Houze S, Paris L, Quinio D, Robert-Gangneux F, Villard O, Villena I, Candolfi E, Pelloux H. Toxoplasma seroconversion with negative or transient immunoglobulin M in pregnant women: myth or reality? A French multicenter retrospective study. J.Clin.Microbiol. 2013 Jul;51(7):2103-11. doi: 10.1128/JCM.00169-13.
98. Dando C, Gabriel KE, Remington JS, Parmley SF. Simple and efficient method for measuring anti-Toxoplasma immunoglobulin antibodies in human sera using complement-mediated lysis of transgenic tachyzoites expressing beta-galactosidase. J.Clin.Microbiol. 2001 Jun;39(6):2122-5.
99. Olariu TR, Remington JS, Montoya JG. Polymerase Chain Reaction in Cerebrospinal Fluid for the Diagnosis of Congenital Toxoplasmosis. Pediatr. Infect. Dis. J. 2014 Jan 17..
100. Guigue N, Menotti J, Hamane S, Derouin F, Garin YJ. Performance of the BioPlex(R) 2200 flow immunoassay (Bio-Rad) in critical cases of serodiagnosis of toxoplasmosis. Clin. Vaccine Immunol. 2014 Jan 29. [Epub ahead of print].
101. Avelino MM, Amaral WN, Rodrigues IM, Rassi AR, Gomes MB, Costa TL, Castro AM. Congenital toxoplasmosis and prenatal care state programs. BMC Infect. Dis. 2014 Jan 18;14:33. doi: 10.1186/1471-2334-14-33.
102. di Carlo P, Romano A, Casuccio A, Cillino S, Schimmenti MG, Mancuso G, la Chiusa S, Novara V, Ingrassia D, Li Vecchi V, Trizzino M, Titone L. Investigation and management of Toxoplasma gondii infection in pregnancy and infancy: a prospective study. Acta Pharmacol. Sin. 2011 Aug;32(8):1063-70. doi: 10.1038/aps.2011.55.
103. Mizejewski GJ. Physiology of Alpha-Fetoprotein as a Biomarker for Perinatal Distress: Relevance to Adverse Pregnancy Outcome. Exp. Biol.Med. 2007,232:993-1004.
104. Ritter M, Ali MY, Grimm CF, Weth R, Mohr L, Bocher WO, Endrulat K, Wedemeyer H, Blum HE, Geissler M. Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma. J.Hepatol. 2004,41:999-1007.
105. Kaur M, Verma IC. Serum alpha feto-protein screening in high risk pregnancies. Indian J.Pediatr. 1995;62:101-7.
106. Cortina-Borja M, Tan HK, Wallon M, Paul M, Prusa A, Buffolano W, Malm G, Salt A, Freeman K, Petersen E, Gilbert RE. European Multicentre Study on Congenital Toxoplasmosis (EMSCOT). Prenatal treatment for serious neurological squeal of congenital toxoplasmosis: an observational prospective cohort study. PLoS Med. 2010,12;7. pii: e1000351.
107. Daffos F, Forestier F, Capella-Pavlovsky M, Thulliez P, Aufrant C, Valenti D et al. Prenatal management of 746 pregnancies at risk for congenital Toxoplasmosis. N. Engl. J. Med. 1998;318:271-275.
108. Berrebi A, Assouline C, Bessieres MH, Lathiere M, Cassaing S, Minville V, Ayoubi JM. Long-term outcome of children with congenital toxoplasmosis. Am. J. Obstet. Gynecol. 2010;203:552.e1-6.
109. Habib FA. Post-treatment assessment of acute Toxoplasma infection during pregnancy. J. Obstet.Gynaecol. 2008;28:593-5.
110. Julliac B, Theophile H, Begorre M, Richez B, Haramburu F. Side effects of spiramycin masquerading as local anesthetic toxicity during labor epidural analgesia. Int. J. Obstet.Anesth 2010;19:331-2.
111. Berrébi A, Assouline C, Bessières MH, Lathière M, Cassaing S, Minville V, Ayoubi JM. Long-term outcome of children with congenital toxoplasmosis. Am. J. Obstet. Gynecol. 2010 Dec;203(6):552.e1-6. doi: 10.1016/j.ajog.2010.06.002.
112. Bessières MH, Berrebi A, Cassaing S, Fillaux J, Cambus JP, Berry A, Assouline C, Ayoubi JM, Magnaval JF. Diagnosis of congenital toxoplasmosis: prenatal andneonatal evaluation of methods used in Toulouse University Hospital andincidence of congenital toxoplasmosis. Mem. Inst. Oswaldo Cruz 2009;104:389-92.
113. Hudson AT, Dickins M, Ginger CD, Gutteridge WE, Holdich T, Hutchinson DB, Pudney M, Randall AW, Latter VS. 566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients. Drugs Exp.Clin. Res. 1991;17:427-35.
114. Oz HS, Hughes W, Rehg J. A rat model for dual opportunistic pathogens: Cryptosporidium parvum and Pneumocystis carinii. Lab. Animal Sci. 1999;49:331-334.
115. Hughes W, Oz HS. Successful prevention and treatment of babesiosis with atovaquone. J. Infect. Dis. 1995;172:1042-1046.
116. Oz HS, Westlund KH. "Human Babesiosis" an emerging transfusion dilemma. Int. J.Hepatol. 2012, Volume 2012, Article ID 431761,5 pages doi:10.1155/2012/431761.
117. Freyre A, Falcon J, Mendez J, Gonzalez M. Toxoplasma gondii: an improved rat model of congenital infection. Exp.Parasitol. 2008;120:142-6.
118. Srivastava IK, Vaidya AB. A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob. Agents Chemother 1999;43:1334-9.
119. Rolan PE, Mercer AJ, Tate E, Benjamin I, Posner J. Disposition of atovaquone in humans. Antimicrob. Agents Chemother 1997;41:1319-21.
120. Dunay IR, Heimesaat MM, Bushrab FN, Muller RH, Stocker H, Arasteh K, Kurowski M, Fitzner R, Borner K, Liesenfeld O. Atovaquone Maintenance Therapy Prevents Reactivation of Toxoplasmic Encephalitis in a Murine Model of Reactivated toxoplasmosis. Antimicrob. Agents Chempther 2004,48, 4848-4854.
121. Dinter D, Gajski G, Garaj-Vrhovac V. An alkaline comet assay study on the antimalarial drug atovaquone in human peripheral blood lymphocytes: a study based on clinically relevant concentrations. J Appl Toxicol 2013,33,56-62. doi: 10.1002/jat.1711.
122. Kaňková S, Sulc J, Flegr J. Increased pregnancy weight gain in women with latent toxoplasmosis and RhD-positivity protection against this effect. Parasitology. 2010 Oct;137(12):1773-9. doi: 10.1017/S0031182010000661.
123. Köhler S, Delwiche CF, Denny PW, Tilney LG, Webster P, Wilson R J M., Jeffrey D. Palmer, David S. Roos. A Plastid of Probable Green Algal Origin in Apicomplexan Parasites Science 1997: 275,1485 -1489. DOI: 10.1126/science.275.5305.1485.
124. Hackstein JH, Mackenstedt U, Mehlhorn H, Meijerink JP, Schubert H, Leunissen JA. Parasitic apicomplexans harbor a chlorophyll a-D1 complex, the potential target fortherapeutic triazines. Parasitol. Res. 1995;81:207-16.
125. Zhou W, Quan JH, Lee YH, Shin DW, Cha GH. Toxoplasma gondii Proliferation Require Down-Regulation of Host Nox4 Expression via Activation of PI3 Kinase/Akt Signaling Pathway. PLoS One. 2013 Jun 18;8(6):e66306. Print 2013.
126. Assis RC, Luns FD, Beletti ME, Assis RL, Nasser NM, Faria ES, Cury MC. Histomorphometry and macroscopic intestinal lesions in broilers infected with Eimeria acervulina. Vet.Parasitol. 2010 Mar 25;168(3-4):185-9. doi: 10.1016/j.vetpar.2009.11.017. Epub 2009 Dec 16.
127. Ajzenberg D, Cogne N, Paris L, Bessieres MH, Thulliez P, Filisetti P, Pelloux H, Marty P, Darde ML. Genotype of 86 Toxoplasma gondii isolates associated with human congenital Toxoplasmosis, and correlation with clinical findings. J. Infect. Dis.2002;186:684-689.
128. Dubey JP, Ferreira LR, Martins J, McLeod R. Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality. Parasitology 2011,14:1-13.
129. Takahashi J, Fukuda T, Tanaka J, Minamitani M, Onouchic K, Makiokad A. Bax-induced apoptosis not demonstrated in the congenital toxoplasmosis in mice. Brain Dev 2001,23: 50-53.
130. Araujo FG, Slifer T. Different Strains of Toxoplasma gondii Induce Different Cytokine Responses in CBA/Ca Mice. Infect. Immun. 2003,71:4171-414.